首页 > 最新文献

F&S science最新文献

英文 中文
Impact of a short-term Western-style diet and hyperandrogenism on adult rhesus macaque ovarian function 短期西式饮食和高雄激素血症对成年恒河猴卵巢功能的影响。
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.02.007
Pamela B. Parker M.D., M.P.H. , Melinda J. Murphy B.S. , Sweta Ravisankar Ph.D. , Shawn L. Chavez Ph.D. , Jon D. Hennebold Ph.D.

Objective

To determine the effect of an obesogenic Western-style diet and hyperandrogenemia on ovarian outcomes.

Design

Experimental, controlled animal study.

Subjects

Post-pubertal rhesus macaque females.

Exposure

A Western-style diet (WSD) (WSD: 36% fat, 45% carbohydrate, 18% protein) combined with exogenously administered testosterone (T) vs. a standard chow diet (control; 15% fat, 59% carbohydrate, 27% protein). Animals underwent controlled ovarian stimulations to assess ovarian follicle development.

Main Outcome Measures

Cycle length, the proportion of ovulatory cycles, and daily levels of estradiol (E2), progesterone, antimüllerian hormone, luteinizing hormone, and follicle-stimulating hormone were compared between control and T+WSD groups through one menstrual cycle. Follicular fluid was assessed for cytokine and steroid content, and retrieved oocytes were evaluated for meiotic maturation and underwent in vitro fertilization. Granulosa cells were analyzed for differential gene expression. Ovaries were removed in early luteal phase (4 days post midcycle estradiol surge) and analyzed for morphological differences.

Results

The T+WSD group demonstrated significantly decreased luteal progesterone levels. We found no differences in cycle length, proportion of ovulatory cycles, day of E2 surge, total E2 synthesis, follicle-stimulating hormone, luteinizing hormone or antimüllerian hormone. Analysis of follicular fluid retrieved from animals undergoing an ovarian stimulation protocol revealed increased vascular endothelial growth factor-A, elevated cortisol:cortisone ratio, and increased testosterone and progesterone levels in the treatment group. Granulosa cells from T+WSD demonstrated significantly up-regulated or down-regulated genes relative to controls, including those related to cell differentiation and migration. The ovarian morphology of treatment animals demonstrated enlarged cystic follicles reminiscent of polycystic ovaries.

Conclusion

Similar to prior studies assessing long-term exposure (5–6 years) to T+WSD in female rhesus macaques beginning before menarche, a 1-year T+WSD treatment in adult, regularly cycling females led to reduced luteal phase progesterone levels and polycystic ovarian morphology. Additionally, short-term T+WSD exposure resulted in altered granulosa cell gene expression. Although 1 year of T+WSD exposure leads to altered luteal progesterone, follicular fluid steroid and cytokine content, and granulosa cell gene expression changes, insults of longer duration are required to exert additional negative effects on ovarian function.
目的:探讨致肥性西式饮食和高雄激素血症对卵巢结局的影响。设计:实验对照动物研究对象:青春期后恒河猴雌性暴露:西式饮食(T+WSD: 36%脂肪,45%碳水化合物,18%蛋白质)结合外源性睾酮与标准鼠粮(对照组,CTRL;15%脂肪,59%碳水化合物,27%蛋白质)。实验动物接受受控卵巢刺激以评估卵泡发育。主要观察指标:比较按CTRL组和按T+WSD组在一个月经周期内的周期长度、排卵周期比例、每日雌二醇(E2)、黄体酮(P4)、AMH、黄体生成素(LH)、促卵泡激素(FSH)水平。对卵泡液进行细胞因子和类固醇含量评估,对提取的卵母细胞进行减数分裂成熟评估,并进行体外受精。对颗粒细胞进行差异基因表达分析。在黄体早期(中期雌二醇激增后4天)切除卵巢,分析形态学差异。结果:T+WSD组黄体P4水平明显降低。我们发现在周期长度、排卵周期比例、E2激增天数、总E2合成、FSH、LH或AMH方面没有差异。从接受卵巢刺激方案的动物中提取的卵泡液分析显示,治疗组血管内皮生长因子- a (VEGFA)升高,皮质醇:可的松比值升高,睾酮和孕酮水平升高。与先前评估雌性恒河猴月经初潮前长期(5-6年)暴露于T+WSD的研究类似,在成年、定期循环的雌性恒河猴中,1年的T+WSD治疗导致黄体期黄体酮水平降低和多囊卵巢形态。此外,短期T+WSD暴露导致颗粒细胞基因表达改变。虽然1年的T+WSD暴露会导致黄体黄体酮、卵泡液类固醇和细胞因子含量的改变,以及颗粒细胞基因表达的变化,但需要更长的时间才能对卵巢功能产生额外的负面影响。
{"title":"Impact of a short-term Western-style diet and hyperandrogenism on adult rhesus macaque ovarian function","authors":"Pamela B. Parker M.D., M.P.H. ,&nbsp;Melinda J. Murphy B.S. ,&nbsp;Sweta Ravisankar Ph.D. ,&nbsp;Shawn L. Chavez Ph.D. ,&nbsp;Jon D. Hennebold Ph.D.","doi":"10.1016/j.xfss.2025.02.007","DOIUrl":"10.1016/j.xfss.2025.02.007","url":null,"abstract":"<div><h3>Objective</h3><div>To determine the effect of an obesogenic Western-style diet and hyperandrogenemia on ovarian outcomes.</div></div><div><h3>Design</h3><div>Experimental, controlled animal study.</div></div><div><h3>Subjects</h3><div>Post-pubertal rhesus macaque females.</div></div><div><h3>Exposure</h3><div>A Western-style diet (WSD) (WSD: 36% fat, 45% carbohydrate, 18% protein) combined with exogenously administered testosterone (T) vs. a standard chow diet (control; 15% fat, 59% carbohydrate, 27% protein). Animals underwent controlled ovarian stimulations to assess ovarian follicle development.</div></div><div><h3>Main Outcome Measures</h3><div>Cycle length, the proportion of ovulatory cycles, and daily levels of estradiol (E2), progesterone, antimüllerian hormone, luteinizing hormone, and follicle-stimulating hormone were compared between control and T+WSD groups through one menstrual cycle. Follicular fluid was assessed for cytokine and steroid content, and retrieved oocytes were evaluated for meiotic maturation and underwent in vitro fertilization. Granulosa cells were analyzed for differential gene expression. Ovaries were removed in early luteal phase (4 days post midcycle estradiol surge) and analyzed for morphological differences.</div></div><div><h3>Results</h3><div>The T+WSD group demonstrated significantly decreased luteal progesterone levels. We found no differences in cycle length, proportion of ovulatory cycles, day of E2 surge, total E2 synthesis, follicle-stimulating hormone, luteinizing hormone or antimüllerian hormone. Analysis of follicular fluid retrieved from animals undergoing an ovarian stimulation protocol revealed increased vascular endothelial growth factor-A, elevated cortisol:cortisone ratio, and increased testosterone and progesterone levels in the treatment group. Granulosa cells from T+WSD demonstrated significantly up-regulated or down-regulated genes relative to controls, including those related to cell differentiation and migration. The ovarian morphology of treatment animals demonstrated enlarged cystic follicles reminiscent of polycystic ovaries.</div></div><div><h3>Conclusion</h3><div>Similar to prior studies assessing long-term exposure (5–6 years) to T+WSD in female rhesus macaques beginning before menarche, a 1-year T+WSD treatment in adult, regularly cycling females led to reduced luteal phase progesterone levels and polycystic ovarian morphology. Additionally, short-term T+WSD exposure resulted in altered granulosa cell gene expression. Although 1 year of T+WSD exposure leads to altered luteal progesterone, follicular fluid steroid and cytokine content, and granulosa cell gene expression changes, insults of longer duration are required to exert additional negative effects on ovarian function.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Pages 141-151"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143525341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kinetics of cell shrinkage and developmental competence of mouse zygotes vitrified following conventional or automated (DaVitri) protocols 采用常规或自动(DaVitri)方法玻璃化的小鼠受精卵的细胞收缩和发育能力动力学。
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.03.006
Javier Guerrero-Sánchez Ms.C. , Andrea Fernández-Toribio Ms.C. , Beatriz Galiano-Cogolludo Ms.C. , Tania García-Martínez Ph.D. , Lucía Mendoza Ph.D. , Gonzalo Fernández-Blanco Ms.C. , Jesús Ramos-Membrive Ms.C. , Joana Fidalgo Ph.D. , Lionel Matthys Ms.C. , José Antonio Horcajadas Ph.D. , Santiago Munné Ph.D. , Pablo Bermejo-Álvarez D.V.M., Ph.D.

Objective

To test the developmental ability of murine zygotes vitrified using a novel vitrification device and microfluidic chip (DaVitri, Overture Life).

Design

Murine zygotes were randomly allocated to 2 groups; one was vitrified using the vitrification device, and the other was following a conventional manual protocol.

Subjects

Murine zygotes obtained in vivo.

Exposure

Automatic vitrification was achieved by a linear exposure to cryoprotectants (CPAs) using the DaVitri device. Manual vitrification was conducted using Kitazato kit.

Main Outcome Measures

Morphokinetic behavior of the zygotes during the exposure to CPAs analyzed by microscopy, developmental rates after thawing, lineage development at the blastocyst stage assessed by immunohistochemistry and light-structured fluorescent microscopy, and survival rates and pup weight after embryo transfer.

Results

Automated vitrification led to a gradual reduction in zygote volume during the equilibration steps preceding ultrafast cooling in liquid nitrogen, as opposed to the conventional manual protocol where sharp changes in zygote volume were observed as a result of exposure to static concentrations of CPAs. Survival rates of the automated procedure were comparable to those of the manual protocol, resulting in ∼95% blastocyst formation rates. Developmental analysis of the resulting blastocysts revealed comparable numbers of total, trophectoderm, and inner cell mass numbers in blastocysts developed from zygotes vitrified under the manual and automated protocols. No differences were found in survival to term or pup weight a D1 or D21.

Conclusion

Automated vitrification using DaVitri device diminished the osmotic stress caused by exposure to CPAs during the equilibration steps and resulted in comparable developmental competence in terms of development to blastocysts, lineage segregation, and survival to term.
目的:研究一种新型玻璃化装置和微流控芯片(DaVitri®,Overture Life)对小鼠受精卵玻璃化后的发育能力。设计:将小鼠受精卵随机分为两组,一组使用玻璃化装置进行玻璃化,另一组采用常规手工方法进行玻璃化。实验对象:体内获得的小鼠受精卵。暴露:自动玻璃化是通过使用DaVitri装置线性暴露于冷冻保护剂来实现的。使用Kitazato®试剂盒进行人工玻璃化。主要观察指标:显微镜分析受精卵暴露于冷冻保护剂期间的形态动力学行为,解冻后的发育率,免疫组织化学和光结构荧光显微镜评估囊胚期的谱系发育,胚胎移植后的存活率和幼犬体重。结果:在液氮中超高速冷却之前的平衡步骤中,自动玻璃化导致受精卵体积逐渐减少,这与传统的人工方案相反,在人工方案中,由于暴露于静态浓度的冷冻保护剂,受精卵体积会发生急剧变化。自动程序的存活率与手动程序相当,导致囊胚形成率为95%。对所得到囊胚的发育分析显示,在人工和自动方法下玻璃化的受精卵中,囊胚的总数量、滋养外胚层和内细胞质量数量相当。D1和D21的存活率和幼崽体重均无差异。结论:采用DaVitri装置的自动玻璃化处理减少了在平衡过程中暴露于CPAs引起的渗透应激,在囊胚发育、谱系分离和存活方面具有相当的发育能力。
{"title":"Kinetics of cell shrinkage and developmental competence of mouse zygotes vitrified following conventional or automated (DaVitri) protocols","authors":"Javier Guerrero-Sánchez Ms.C. ,&nbsp;Andrea Fernández-Toribio Ms.C. ,&nbsp;Beatriz Galiano-Cogolludo Ms.C. ,&nbsp;Tania García-Martínez Ph.D. ,&nbsp;Lucía Mendoza Ph.D. ,&nbsp;Gonzalo Fernández-Blanco Ms.C. ,&nbsp;Jesús Ramos-Membrive Ms.C. ,&nbsp;Joana Fidalgo Ph.D. ,&nbsp;Lionel Matthys Ms.C. ,&nbsp;José Antonio Horcajadas Ph.D. ,&nbsp;Santiago Munné Ph.D. ,&nbsp;Pablo Bermejo-Álvarez D.V.M., Ph.D.","doi":"10.1016/j.xfss.2025.03.006","DOIUrl":"10.1016/j.xfss.2025.03.006","url":null,"abstract":"<div><h3>Objective</h3><div>To test the developmental ability of murine zygotes vitrified using a novel vitrification device and microfluidic chip (DaVitri, Overture Life).</div></div><div><h3>Design</h3><div>Murine zygotes were randomly allocated to 2 groups; one was vitrified using the vitrification device, and the other was following a conventional manual protocol.</div></div><div><h3>Subjects</h3><div>Murine zygotes obtained in vivo.</div></div><div><h3>Exposure</h3><div>Automatic vitrification was achieved by a linear exposure to cryoprotectants (CPAs) using the DaVitri device. Manual vitrification was conducted using Kitazato kit.</div></div><div><h3>Main Outcome Measures</h3><div>Morphokinetic behavior of the zygotes during the exposure to CPAs analyzed by microscopy, developmental rates after thawing, lineage development at the blastocyst stage assessed by immunohistochemistry and light-structured fluorescent microscopy, and survival rates and pup weight after embryo transfer.</div></div><div><h3>Results</h3><div>Automated vitrification led to a gradual reduction in zygote volume during the equilibration steps preceding ultrafast cooling in liquid nitrogen, as opposed to the conventional manual protocol where sharp changes in zygote volume were observed as a result of exposure to static concentrations of CPAs. Survival rates of the automated procedure were comparable to those of the manual protocol, resulting in ∼95% blastocyst formation rates. Developmental analysis of the resulting blastocysts revealed comparable numbers of total, trophectoderm, and inner cell mass numbers in blastocysts developed from zygotes vitrified under the manual and automated protocols. No differences were found in survival to term or pup weight a D1 or D21.</div></div><div><h3>Conclusion</h3><div>Automated vitrification using DaVitri device diminished the osmotic stress caused by exposure to CPAs during the equilibration steps and resulted in comparable developmental competence in terms of development to blastocysts, lineage segregation, and survival to term.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Pages 186-194"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced ovarian FKBP51 expression is associated with ovarian aging: a molecular insight for age-related fertility in women 卵巢FKBP51表达增强与卵巢衰老相关:女性年龄相关生育的分子洞察
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.01.004
Papri Sarkar M.D. , Monica Moore M.Sc , Asli Ozmen PhD , Busra Cetinkaya-Un Ph.D , Vitko Julie M.D. , Anthony N. Imudia M.D , Charles J. Lockwood M.D. , Umit A. Kayisli Ph.D. , Ozlem Guzeloglu-Kayisli Ph.D.
<div><h3>Objective</h3><div>To study the relationship between FK506-binding protein 51 (FKBP51) and ovarian aging and/or diminished ovarian reserve (DOR) in human ovaries by comparing FKBP51 levels in granulosa cells (GCs) and cumulus cells (CCs), collected during controlled ovarian stimulation (COS) from women of advanced reproductive age and/or with a diagnosis of DOR with that of young women with normal ovarian reserve. To explore the association between increased FKBP51 expression and human ovarian aging further, expression of FKBP51 was compared in ovarian stroma of postmenopausal vs. premenopausal women. Lastly, this relation was further queried by comparing ovarian expression of several collagen genes as markers of ovarian fibrosis in 14-month-old wild-type (<em>Fkbp5</em><sup><em>+/+</em></sup>) and <em>Fkbp5</em> knockout (<em>Fkbp5</em><sup><em>−/−</em></sup>) mice.</div></div><div><h3>Design</h3><div>Laboratory-based experimental study.</div></div><div><h3>Subjects</h3><div>Samples collected included follicular fluid, CCs, GCs, and serum from group 1: young women with normal ovarian reserve (<35 years; n = 12); group 2: DOR (antimüllerian hormone <1 ng/mL; n = 10); and group 3: women of advanced age with normal ovarian reserve (>37 years; n = 8). Ovarian stromal tissues obtained from surgical specimen of post-menopausal (50–65 years; n = 6) and pre-menopausal (18–30 years; n = 6). Ovarian tissues from 14-month-old <em>Fkbp5</em><sup><em>+/+</em></sup> <em>and Fkbp5</em><sup><em>−/−</em></sup> mice. All the experiments were performed at an academic-affiliated assisted reproductive technology unit/laboratory.</div></div><div><h3>Exposure</h3><div>Comparison of FKBP51 expression in GCs and CCs from women undergoing COS, ovarian stromal tissue from pre- and post-menopausal women, and ovarian tissue from aged <em>Fkbp5</em><sup><em>+/+</em></sup> <em>and Fkbp5</em><sup><em>−/−</em></sup> mice.</div></div><div><h3>Main Outcome Measures</h3><div>(1) Level of FKBP51 in human GCs and CCs, collected during COS by performing real-time quantitative polymerase chain reaction (qPCR). (2) Immunohistochemistry to detect FKBP51 levels and Picrosirius Red staining to detect collagen deposition in human ovarian stromal tissue. (3) Real-time qPCR to compare expression levels of several collagen genes in <em>Fkbp5</em><sup><em>+/+</em></sup> and <em>Fkbp5</em><sup><em>−/−</em></sup> old mice ovaries. Serum and follicular fluid levels of transforming growth factor β1, and soluble endoglin measured by enzyme-linked immunosorbent assay.</div></div><div><h3>Results</h3><div>Immunohistochemistry revealed that FKBP51 histologic score levels in ovarian stromal tissue were significantly higher in postmenopausal vs. premenopausal women (mean ± SEM, 160.52 ± 17.75 vs. 120.67 ± 14.33; <em>P</em>=.002). Stronger Picrosirius Red staining, suggestive of fibrosis, was seen in ovarian stromal tissue of postmenopausal vs. premenopausal women (54.06 ± 6.94 vs. 37.5
目的:通过比较高龄和/或诊断为DOR的卵巢控制性刺激(COS)时收集的颗粒细胞(GC)和积云细胞(CC)中fk506结合蛋白51 (FKBP51)与卵巢储备功能正常的年轻女性的fk506结合蛋白51 (FKBP51)水平,研究fk506结合蛋白51与卵巢老化和/或卵巢储备功能减退(DOR)之间的关系。为了进一步探讨FKBP51表达升高与人类卵巢衰老的关系,我们比较了绝经后和绝经前女性卵巢间质中FKBP51的表达。最后,通过比较14月龄野生型(Fkbp5+/+)和Fkbp5敲除型(Fkbp5-/-)小鼠卵巢中几种胶原基因作为卵巢纤维化标志物的表达,进一步探究这种关系。设计:基于实验室的实验研究。背景:学术附属辅助生殖技术单位/实验室受试者:(1)收集的样本包括第1组的卵泡液(FF)、CC、GC和血清:卵巢储备正常的年轻女性(37岁;n = 8)。(2)绝经后(50 ~ 65岁)手术标本获得的卵巢间质组织;N =6)和绝经前(18-30岁;n = 6)。(3) Fkbp5+/+和Fkbp5-/-小鼠14月龄卵巢组织。暴露:比较FKBP51在COS妇女GC和CC、绝经前和绝经后妇女卵巢间质组织、老年Fkbp5+/+和Fkbp5-/-小鼠卵巢组织中的表达。主要观察指标:(1)人GC和CC中FKBP51的水平,通过RT-qPCR (RT-qPCR)在COS期间收集。(2)免疫组化(IHC)检测FKBP51水平,Picrosirius Red染色(PSR)检测人卵巢间质组织胶原沉积。(3) RT-qPCR比较Fkbp5+/+和Fkbp5-/-老年小鼠卵巢中几种胶原蛋白基因的表达水平。(4) ELISA法测定血清和FF中TGF-β1、可溶性内啡肽水平。结果:IHC显示绝经后妇女卵巢间质组织中FKBP51 HSCORE水平明显高于绝经前妇女(Mean±SEM;160.52±17.75 vs. 120.67±14.33,P= 0.002)。绝经后和绝经前妇女的小天狼星红染色较强,提示纤维化(54.06±6.94比37.50±14.29,P=0.02)。qPCR分析显示:1)14月龄Fkbp5-/-vs卵巢Col1a1、Col1a2、Col3a1水平显著降低。Fkbp5 + / +老鼠;2)老年女性积云细胞中FKBP5水平明显高于年轻女性(1.71±0.22比1.11±0.15,P= 0.03);3)与年龄匹配的对照组相比,DOR女性颗粒细胞中FKBP5水平高出约3倍(3.22±1.11比1.30±0.54 P= 0.03)。结论:本研究首次揭示了FKBP51在人卵巢中的表达谱及其在卵巢衰老中的潜在作用。我们的研究结果表明FKBP51的上调与卵巢衰老有关。此外,在接受IVF治疗的女性中,DOR患者或产妇生育年龄较晚且预后较差的女性中FKBP51表达增强。因此,靶向抑制FKBP51表达和/或活性的药物可能延缓卵巢衰老或治疗卵巢早衰。
{"title":"Enhanced ovarian FKBP51 expression is associated with ovarian aging: a molecular insight for age-related fertility in women","authors":"Papri Sarkar M.D. ,&nbsp;Monica Moore M.Sc ,&nbsp;Asli Ozmen PhD ,&nbsp;Busra Cetinkaya-Un Ph.D ,&nbsp;Vitko Julie M.D. ,&nbsp;Anthony N. Imudia M.D ,&nbsp;Charles J. Lockwood M.D. ,&nbsp;Umit A. Kayisli Ph.D. ,&nbsp;Ozlem Guzeloglu-Kayisli Ph.D.","doi":"10.1016/j.xfss.2025.01.004","DOIUrl":"10.1016/j.xfss.2025.01.004","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To study the relationship between FK506-binding protein 51 (FKBP51) and ovarian aging and/or diminished ovarian reserve (DOR) in human ovaries by comparing FKBP51 levels in granulosa cells (GCs) and cumulus cells (CCs), collected during controlled ovarian stimulation (COS) from women of advanced reproductive age and/or with a diagnosis of DOR with that of young women with normal ovarian reserve. To explore the association between increased FKBP51 expression and human ovarian aging further, expression of FKBP51 was compared in ovarian stroma of postmenopausal vs. premenopausal women. Lastly, this relation was further queried by comparing ovarian expression of several collagen genes as markers of ovarian fibrosis in 14-month-old wild-type (&lt;em&gt;Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;+/+&lt;/em&gt;&lt;/sup&gt;) and &lt;em&gt;Fkbp5&lt;/em&gt; knockout (&lt;em&gt;Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;−/−&lt;/em&gt;&lt;/sup&gt;) mice.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design&lt;/h3&gt;&lt;div&gt;Laboratory-based experimental study.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Subjects&lt;/h3&gt;&lt;div&gt;Samples collected included follicular fluid, CCs, GCs, and serum from group 1: young women with normal ovarian reserve (&lt;35 years; n = 12); group 2: DOR (antimüllerian hormone &lt;1 ng/mL; n = 10); and group 3: women of advanced age with normal ovarian reserve (&gt;37 years; n = 8). Ovarian stromal tissues obtained from surgical specimen of post-menopausal (50–65 years; n = 6) and pre-menopausal (18–30 years; n = 6). Ovarian tissues from 14-month-old &lt;em&gt;Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;+/+&lt;/em&gt;&lt;/sup&gt; &lt;em&gt;and Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;−/−&lt;/em&gt;&lt;/sup&gt; mice. All the experiments were performed at an academic-affiliated assisted reproductive technology unit/laboratory.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Exposure&lt;/h3&gt;&lt;div&gt;Comparison of FKBP51 expression in GCs and CCs from women undergoing COS, ovarian stromal tissue from pre- and post-menopausal women, and ovarian tissue from aged &lt;em&gt;Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;+/+&lt;/em&gt;&lt;/sup&gt; &lt;em&gt;and Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;−/−&lt;/em&gt;&lt;/sup&gt; mice.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Main Outcome Measures&lt;/h3&gt;&lt;div&gt;(1) Level of FKBP51 in human GCs and CCs, collected during COS by performing real-time quantitative polymerase chain reaction (qPCR). (2) Immunohistochemistry to detect FKBP51 levels and Picrosirius Red staining to detect collagen deposition in human ovarian stromal tissue. (3) Real-time qPCR to compare expression levels of several collagen genes in &lt;em&gt;Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;+/+&lt;/em&gt;&lt;/sup&gt; and &lt;em&gt;Fkbp5&lt;/em&gt;&lt;sup&gt;&lt;em&gt;−/−&lt;/em&gt;&lt;/sup&gt; old mice ovaries. Serum and follicular fluid levels of transforming growth factor β1, and soluble endoglin measured by enzyme-linked immunosorbent assay.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Immunohistochemistry revealed that FKBP51 histologic score levels in ovarian stromal tissue were significantly higher in postmenopausal vs. premenopausal women (mean ± SEM, 160.52 ± 17.75 vs. 120.67 ± 14.33; &lt;em&gt;P&lt;/em&gt;=.002). Stronger Picrosirius Red staining, suggestive of fibrosis, was seen in ovarian stromal tissue of postmenopausal vs. premenopausal women (54.06 ± 6.94 vs. 37.5","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Pages 152-163"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143017305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic insights into the immunological basis of male infertility: a translational perspective 男性不育症的免疫学基础的遗传见解:翻译的观点。
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.02.002
Yi Wang M.D. , Yanggang Hong M.D.

Objective

To elaborate the causal relationships between specific immunocyte phenotypes and male infertility.

Design

Mendelian randomization using genome-wide association study data.

Subjects

Large cohorts of European ancestry.

Exposure

731 immunocyte phenotypes or male infertility.

Main Outcomes Measures

Genetic variants were used as instrumental variables to infer causality, minimizing confounding and bias. The causal associations were assessed using the inverse variance-weighted (IVW) method for primary analysis, and the findings were validated using MR-Egger, Weighted Median, Simple Mode, and Weighted Mode approaches. Additional sensitivity analyses were performed to validate the robustness of the findings.

Results

Our analysis identified significant causal associations between specific immunocyte phenotypes and male infertility. Phenotypes such as naive-mature B cell %lymphocyte (odds ratio [OR] = 1.257) and IgD− CD38dim %B cell (OR = 1.100) were positively associated with increased infertility risk, whereas phenotypes like CD39+ CD8br %T cell (OR = 0.856) and B cells activator of the TNF-α family receptor (BAFF-R) on transitional (OR = 0.833) were negatively associated, suggesting a protective effect. Additionally, reverse MR analysis revealed that male infertility might causally affect certain immunocyte phenotypes, including CD14- CD16+ monocyte %monocyte (OR = 1.049).

Conclusion

This study provides robust evidence for the causal role of specific immunocyte phenotypes in male infertility and highlights the bidirectional relationship between immune function and reproductive health. These findings provide new insights into the immunological factors contributing to male infertility and suggest potential biomarkers and therapeutic targets for future research and clinical interventions.
目的:明确特异性免疫细胞表型与男性不育症的因果关系。设计:孟德尔随机化,采用全基因组关联研究数据。设置:公开可用的全基因组关联研究数据。研究对象:大量欧洲血统人群。暴露:731免疫细胞表型或男性不育。主要结果测量:遗传变异作为工具变量来推断因果关系,最大限度地减少混淆和偏差。因果关系采用逆方差加权(IVW)方法进行初步分析,并使用MR-Egger、加权中位数、简单模式和加权模式方法验证结果。进行额外的敏感性分析以验证结果的稳健性。结果:我们的分析确定了特异性免疫细胞表型与男性不育之间的显著因果关系。未成熟B细胞%淋巴细胞(OR = 1.257, P = 0.009)和IgD- CD38dim %B细胞(OR = 1.100, P = 0.021)与不育风险增加呈正相关,而CD39+ CD8br %T细胞(OR = 0.856, P = 0.021)和bba - r细胞(OR = 0.833, P = 0.002)表型与不育风险增加负相关,提示有保护作用。此外,反向MR分析显示,男性不育可能会影响某些免疫细胞表型,包括CD14- CD16+单核细胞%单核细胞(OR = 1.049, P = 0.007)。结论:本研究为特异性免疫细胞表型在男性不育中的因果作用提供了强有力的证据,并强调了免疫功能与生殖健康之间的双向关系。这些发现为男性不育的免疫因素提供了新的见解,并为未来的研究和临床干预提供了潜在的生物标志物和治疗靶点。
{"title":"Genetic insights into the immunological basis of male infertility: a translational perspective","authors":"Yi Wang M.D. ,&nbsp;Yanggang Hong M.D.","doi":"10.1016/j.xfss.2025.02.002","DOIUrl":"10.1016/j.xfss.2025.02.002","url":null,"abstract":"<div><h3>Objective</h3><div>To elaborate the causal relationships between specific immunocyte phenotypes and male infertility.</div></div><div><h3>Design</h3><div>Mendelian randomization using genome-wide association study data.</div></div><div><h3>Subjects</h3><div>Large cohorts of European ancestry.</div></div><div><h3>Exposure</h3><div>731 immunocyte phenotypes or male infertility.</div></div><div><h3>Main Outcomes Measures</h3><div>Genetic variants were used as instrumental variables to infer causality, minimizing confounding and bias. The causal associations were assessed using the inverse variance-weighted (IVW) method for primary analysis, and the findings were validated using MR-Egger, Weighted Median, Simple Mode, and Weighted Mode approaches. Additional sensitivity analyses were performed to validate the robustness of the findings.</div></div><div><h3>Results</h3><div>Our analysis identified significant causal associations between specific immunocyte phenotypes and male infertility. Phenotypes such as naive-mature B cell %lymphocyte (odds ratio [OR] = 1.257) and IgD− CD38dim %B cell (OR = 1.100) were positively associated with increased infertility risk, whereas phenotypes like CD39+ CD8br %T cell (OR = 0.856) and B cells activator of the TNF-α family receptor (BAFF-R) on transitional (OR = 0.833) were negatively associated, suggesting a protective effect. Additionally, reverse MR analysis revealed that male infertility might causally affect certain immunocyte phenotypes, including CD14- CD16+ monocyte %monocyte (OR = 1.049).</div></div><div><h3>Conclusion</h3><div>This study provides robust evidence for the causal role of specific immunocyte phenotypes in male infertility and highlights the bidirectional relationship between immune function and reproductive health. These findings provide new insights into the immunological factors contributing to male infertility and suggest potential biomarkers and therapeutic targets for future research and clinical interventions.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Pages 130-140"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prioritization of potential drug targets in ovarian-related diseases: Mendelian randomization and colocalization analyses 卵巢相关疾病中潜在药物靶点的优先排序:孟德尔随机化和共定位分析
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.02.003
Yanggang Hong M.D.

Objective

To identify key genes and potential drug targets for ovarian-related diseases through genome-wide Mendelian randomization (MR) and colocalization analyses.

Design

We conducted a comprehensive two-sample MR analysis to estimate the causal effects of blood expression quantitative trait loci (eQTLs) on ovarian-related diseases, followed by colocalization analyses to verify the robustness of the expression instrumental variables (IVs). Phenome-wide association studies (PheWAS) were also performed to evaluate the horizontal pleiotropy of potential drug targets and possible side effects.

Subjects

Large cohorts of European ancestry.

Exposure

The exposure in this study was the genetic variants (eQTLs) associated with gene expression levels, considered a form of lifelong exposure. Expression quantitative trait loci data were obtained from the eQTLGen Consortium, encompassing 16,987 genes and 31,684 cis-eQTLs derived from blood samples of healthy individuals of European ancestry.

Main Outcome Measures

The primary outcome measures were the identification of genes causally associated with ovarian-related diseases and the validation of these genes as potential therapeutic targets.

Results

Our study revealed that specific genes such as CD163L1, PPP3CA, MTAP, F12, NRM, BANK1, ZNF66, GNA15, and SLC6A9 were associated with ovarian endometriosis, ovarian cysts, and polycystic ovarian syndrome. Through MR and colocalization analyses, we identified potential drug targets, including CTNNB1, PTPN7, and ABCB4, with strong evidence of colocalization with ovarian-related diseases. Sensitivity analyses confirmed the robustness of our findings, showing no evidence of horizontal pleiotropy or heterogeneity.

Conclusion

This research highlights the significance of precision medicine approaches in identifying genetic factors underlying ovarian-related diseases and provides a foundation for developing targeted therapies, enhancing diagnostic accuracy, and improving treatment strategies for ovarian-related diseases.
目的:通过全基因组孟德尔随机化(MR)和共定位分析,确定卵巢相关疾病的关键基因和潜在药物靶点:通过全基因组孟德尔随机化(MR)和共定位分析,确定卵巢相关疾病的关键基因和潜在药物靶点:我们进行了全面的双样本 MR 分析,以估计血液表达定量性状位点(eQTLs)对卵巢相关疾病的因果效应,然后进行共定位分析,以验证表达工具变量(IVs)的稳健性。此外,还进行了全表型关联研究(PheWAS),以评估潜在药物靶点的水平多效性和可能的副作用:公开的全基因组关联研究数据:eQTL数据来自eQTLGen联盟,包括16,987个基因和31,684个顺式-eQTL,这些数据来自欧洲血统的健康个体的血液样本。主要结果指标:主要结果指标是确定与卵巢相关疾病有因果关系的基因,并验证这些基因是潜在的治疗靶点:我们的研究发现,CD163L1、PPP3CA、MTAP、F12、NRM、BANK1、ZNF66、GNA15 和 SLC6A9 等特定基因与卵巢子宫内膜异位症、卵巢囊肿和多囊卵巢综合征有关。通过磁共振和共定位分析,我们确定了潜在的药物靶点,包括 CTNNB1、PTPN7 和 ABCB4,它们与卵巢相关疾病的共定位证据确凿。敏感性分析证实了我们研究结果的稳健性,没有发现横向多效性或异质性的证据:这项研究强调了精准医学方法在确定卵巢相关疾病的遗传因素方面的重要性,并为开发靶向疗法、提高诊断准确性和改善卵巢相关疾病的治疗策略奠定了基础。
{"title":"Prioritization of potential drug targets in ovarian-related diseases: Mendelian randomization and colocalization analyses","authors":"Yanggang Hong M.D.","doi":"10.1016/j.xfss.2025.02.003","DOIUrl":"10.1016/j.xfss.2025.02.003","url":null,"abstract":"<div><h3>Objective</h3><div>To identify key genes and potential drug targets for ovarian-related diseases through genome-wide Mendelian randomization (MR) and colocalization analyses.</div></div><div><h3>Design</h3><div>We conducted a comprehensive two-sample MR analysis to estimate the causal effects of blood expression quantitative trait loci (eQTLs) on ovarian-related diseases, followed by colocalization analyses to verify the robustness of the expression instrumental variables (IVs). Phenome-wide association studies (PheWAS) were also performed to evaluate the horizontal pleiotropy of potential drug targets and possible side effects.</div></div><div><h3>Subjects</h3><div>Large cohorts of European ancestry.</div></div><div><h3>Exposure</h3><div>The exposure in this study was the genetic variants (eQTLs) associated with gene expression levels, considered a form of lifelong exposure. Expression quantitative trait loci data were obtained from the eQTLGen Consortium, encompassing 16,987 genes and 31,684 cis-eQTLs derived from blood samples of healthy individuals of European ancestry.</div></div><div><h3>Main Outcome Measures</h3><div>The primary outcome measures were the identification of genes causally associated with ovarian-related diseases and the validation of these genes as potential therapeutic targets.</div></div><div><h3>Results</h3><div>Our study revealed that specific genes such as CD163L1, PPP3CA, MTAP, F12, NRM, BANK1, ZNF66, GNA15, and SLC6A9 were associated with ovarian endometriosis, ovarian cysts, and polycystic ovarian syndrome. Through MR and colocalization analyses, we identified potential drug targets, including CTNNB1, PTPN7, and ABCB4, with strong evidence of colocalization with ovarian-related diseases. Sensitivity analyses confirmed the robustness of our findings, showing no evidence of horizontal pleiotropy or heterogeneity.</div></div><div><h3>Conclusion</h3><div>This research highlights the significance of precision medicine approaches in identifying genetic factors underlying ovarian-related diseases and provides a foundation for developing targeted therapies, enhancing diagnostic accuracy, and improving treatment strategies for ovarian-related diseases.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Pages 164-176"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “From the Editor-in-Chief” (F S Sci 2025;6:1–3) “来自总编辑”的勘误表(F S Sci 2025;6:1-3)。
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.02.005
{"title":"Corrigendum to “From the Editor-in-Chief” (F S Sci 2025;6:1–3)","authors":"","doi":"10.1016/j.xfss.2025.02.005","DOIUrl":"10.1016/j.xfss.2025.02.005","url":null,"abstract":"","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Page 261"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Editor-in-Chief 来自总编辑。
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.04.001
William H. Catherino M.D., Ph.D.
{"title":"From the Editor-in-Chief","authors":"William H. Catherino M.D., Ph.D.","doi":"10.1016/j.xfss.2025.04.001","DOIUrl":"10.1016/j.xfss.2025.04.001","url":null,"abstract":"","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Page 117"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143797057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Direct assessment of hereditary hemochromatosis in preimplantation genetic testing 胚胎植入前基因检测对遗传性血色素沉着症的直接评估。
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2024.12.003
Qinnan Zhang Ph.D., Maria Katz M.Sc., Benjamin Podgursky M.Sc., Nicholas Schuch B.S., Shenglai Li M.Sc., Noor Siddiqui M.Sc., Funda Suer Ph.D., Yuntao Xia Ph.D.

Objective

Hereditary hemochromatosis (HH) is a common genetic disorder characterized by iron overload, which, if undiagnosed, can lead to severe organ damage. There are 4 types of HH. Type 1 HH, the most common form, is primarily caused by a common variant in Western Europe (p.Cys282Tyr, C282Y, or c.845 G>A). It is generally preventable during in vitro fertilization if proper genetic testing is performed before implantation. Here, we demonstrated a direct detection and cost-effective approach using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in preimplantation genetic testing (PGT) settings.

Design

We began by validating the assay with genomic deoxyribonucleic acid (DNA) from Coriell cell lines of known HFE C282Y genotypes, followed by testing patients’ genomic DNA samples. After establishing the assay on genomic DNA, we extended the assay to whole-genome amplified DNA from embryo biopsies.

Subjects

The subjects include cell line samples and human specimens and human embryo biopsies.

Exposure

Patients and embryos either carried or did not carry the HFE C282Y variant in their genome. No intervention was applied.

Main Outcome Measures

The readout included the genotype of samples at the HFE C282Y locus and accuracy of PCR-RFLP results.

Results

An accuracy of >99% was achieved across 80 cell line samples, 38 patient samples, and 81 embryo biopsies.

Conclusion

In this study, we demonstrated the feasibility of using the PCR-RFLP approach to PGT. Specifically, we validated the assay for the HFE C282Y variant, the primary cause of type 1 hemochromatosis. The assay was tested on genomic DNA and DNA resulting from whole-genome amplification, achieving >99% accuracy, sensitivity, precision, and specificity. These results also suggest the possibility for extending the PCR-RFLP approach to cover a broader range of conditions, such as spinal muscular atrophy, to benefit more patients currently ineligible for testing at PGT laboratories.
目的:遗传性血色素沉着症(HH)是一种常见的以铁超载为特征的遗传性疾病,如果不及时诊断,可导致严重的器官损害。HH有四种类型。1型HH是最常见的形式,主要是由西欧的一种常见变体(p.Cys282Tyr, C282Y或c.845)引起的G >)。如果在植入前进行适当的基因检测,通常可以在体外受精(IVF)期间预防。在这里,我们展示了在PGT设置中使用PCR-RFLP的直接检测和经济有效的方法。设计:我们首先用已知HFE C282Y基因型的科里尔细胞系的基因组DNA验证该分析,然后测试患者的基因组DNA样本。在建立基因组DNA检测后,我们将该检测扩展到胚胎活检的全基因组扩增DNA。研究对象:研究对象包括细胞系样本和人体标本,以及人类胚胎活组织检查。暴露:患者和胚胎在其基因组中携带或不携带HFE C282Y变体。未进行干预。主要观察指标:读数包括样本在HFE C282Y位点的基因型和PCR-RFLP结果的准确性。结果:在80个细胞系样本、38个患者样本和81个胚胎活检中,准确率达到99%以上。结论:在本研究中,我们证明了PCR-RFLP方法用于胚胎着床前基因检测的可行性。具体来说,我们验证了HFE C282Y变异的检测,HFE C282Y变异是1型血色素沉着病的主要原因。该方法对基因组DNA和全基因组扩增产生的DNA进行了测试,准确度、灵敏度、精密度和特异性均超过99%。这些结果还表明,有可能将PCR-RFLP方法扩展到更广泛的疾病,如SMA,以使更多目前不适合在PGT实验室进行检测的患者受益。
{"title":"Direct assessment of hereditary hemochromatosis in preimplantation genetic testing","authors":"Qinnan Zhang Ph.D.,&nbsp;Maria Katz M.Sc.,&nbsp;Benjamin Podgursky M.Sc.,&nbsp;Nicholas Schuch B.S.,&nbsp;Shenglai Li M.Sc.,&nbsp;Noor Siddiqui M.Sc.,&nbsp;Funda Suer Ph.D.,&nbsp;Yuntao Xia Ph.D.","doi":"10.1016/j.xfss.2024.12.003","DOIUrl":"10.1016/j.xfss.2024.12.003","url":null,"abstract":"<div><h3>Objective</h3><div>Hereditary hemochromatosis (HH) is a common genetic disorder characterized by iron overload, which, if undiagnosed, can lead to severe organ damage. There are 4 types of HH. Type 1 HH, the most common form, is primarily caused by a common variant in Western Europe (p.Cys282Tyr, C282Y, or c.845 G&gt;A). It is generally preventable during in vitro fertilization if proper genetic testing is performed before implantation. Here, we demonstrated a direct detection and cost-effective approach using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in preimplantation genetic testing (PGT) settings.</div></div><div><h3>Design</h3><div>We began by validating the assay with genomic deoxyribonucleic acid (DNA) from Coriell cell lines of known HFE C282Y genotypes, followed by testing patients’ genomic DNA samples. After establishing the assay on genomic DNA, we extended the assay to whole-genome amplified DNA from embryo biopsies.</div></div><div><h3>Subjects</h3><div>The subjects include cell line samples and human specimens and human embryo biopsies.</div></div><div><h3>Exposure</h3><div>Patients and embryos either carried or did not carry the HFE C282Y variant in their genome. No intervention was applied.</div></div><div><h3>Main Outcome Measures</h3><div>The readout included the genotype of samples at the HFE C282Y locus and accuracy of PCR-RFLP results.</div></div><div><h3>Results</h3><div>An accuracy of &gt;99% was achieved across 80 cell line samples, 38 patient samples, and 81 embryo biopsies.</div></div><div><h3>Conclusion</h3><div>In this study, we demonstrated the feasibility of using the PCR-RFLP approach to PGT. Specifically, we validated the assay for the HFE C282Y variant, the primary cause of type 1 hemochromatosis. The assay was tested on genomic DNA and DNA resulting from whole-genome amplification, achieving &gt;99% accuracy, sensitivity, precision, and specificity. These results also suggest the possibility for extending the PCR-RFLP approach to cover a broader range of conditions, such as spinal muscular atrophy, to benefit more patients currently ineligible for testing at PGT laboratories.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Pages 195-201"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stearoyl–coenzyme A desaturase enhances cell survival in human uterine leiomyoma 硬脂酰辅酶A去饱和酶提高人子宫平滑肌瘤细胞存活率。
Pub Date : 2025-05-01 DOI: 10.1016/j.xfss.2025.01.005
Allison S. Komorowski M.D., John S. Coon V M.S., Melania Anton B.S., Azna Zuberi Ph.D., Olivia Sotos B.S., Serdar E. Bulun M.D., Ping Yin M.D., Ph.D.

Objective

Stearoyl-CoA desaturase (SCD1) is an enzyme that catalyzes the conversion of saturated delta-9 fatty acids to monounsaturated fatty acids. SCD1 is highly expressed in various cancers and facilitates cancer cell survival, tumor growth, and metastasis. This study aimed to assess SCD1 expression and function in uterine leiomyoma and matched myometrial tissue and evaluate the impact of SCD1 inhibition on leiomyoma cell viability and apoptosis.

Design

Gene set enrichment analysis was performed to determine whether lipid metabolism pathways are dysregulated in leiomyoma. To assess the function of SCD1, primary leiomyoma and myometrial cells, as well as a CRISPR-engineered leiomyoma-relevant MED12 mutant human uterine smooth muscle (UtSM) cell line, were treated with SCD1 small interfering RNA or a small molecule inhibitor of SCD1, CAY10566. Cell viability and apoptosis assays, real-time quantitative polymerase chain reaction, and immunoblot analyses were performed to evaluate cell function in response to treatment.

Subjects

Leiomyoma and myometrial tissues were obtained from premenopausal individuals designated female at birth (n = 30) undergoing myomectomy or hysterectomy.

Exposure

SCD1 inhibition by small interfering RNA and CAY10566 treatment.

Main Outcome Measures

Messenger RNA (mRNA) and protein levels and cell viability and apoptosis.

Results

Gene set enrichment analysis revealed that the cholesterol homeostasis pathway was significantly different in leiomyoma vs. adjacent myometrial tissues. Among the genes in this pathway, SCD1 mRNA levels were found to be significantly higher in leiomyoma than in matched myometrium. SCD1 inhibition by small interfering RNA or CAY10566 decreased antiapoptotic BCL2 mRNA and protein levels and cell viability in primary leiomyoma but not myometrial cells. SCD1 protein levels were significantly higher in the mutant MED12 UtSM cell line than in the wild-type MED12 UtSM cell line. CAY10566 treatment specifically decreased cell viability and increased apoptosis in mutant MED12 UtSM cells, with increased protein levels of cleaved caspase 3, cleaved PARP, and DDIT3 in mutant MED12 UtSM but not in wild-type MED12 UtSM cells.

Conclusion

SCD1, an enzyme involved in lipid homeostasis, may play an important role in promoting leiomyoma growth and represents a novel target for the treatment of leiomyoma.
目的:硬脂酰辅酶a去饱和酶(SCD1)是一种催化饱和δ -9脂肪酸转化为单不饱和脂肪酸的酶。SCD1在多种癌症中高表达,促进癌细胞存活、肿瘤生长和转移。本研究旨在评估SCD1在子宫平滑肌瘤及匹配子宫肌瘤组织中的表达和功能,并评估SCD1抑制对子宫平滑肌瘤细胞活力和凋亡的影响。设计:进行基因集富集分析以确定平滑肌瘤中脂质代谢途径是否失调。为了评估SCD1的功能,用SCD1小分子干扰RNA或SCD1小分子抑制剂CAY10566处理原发性平滑肌瘤和子宫肌瘤细胞,以及crispr工程的平滑肌瘤相关MED12突变人子宫平滑肌(UtSM)细胞系。通过细胞活力和凋亡测定、实时定量聚合酶链反应和免疫印迹分析来评估细胞功能对治疗的反应。研究对象:子宫肌瘤和子宫肌瘤组织取自绝经前女性(n = 30)进行子宫肌瘤切除术或子宫切除术的患者。暴露:通过小干扰RNA和CAY10566治疗抑制SCD1。主要观察指标:信使RNA (mRNA)和蛋白水平、细胞活力和凋亡。结果:基因集富集分析显示,胆固醇稳态途径在平滑肌瘤和邻近子宫肌瘤组织中有显著差异。在该通路中的基因中,发现平滑肌瘤中的SCD1 mRNA水平明显高于匹配的肌层。小干扰RNA或CAY10566抑制SCD1可降低原发性平滑肌瘤的抗凋亡BCL2 mRNA和蛋白水平以及细胞活力,但对子宫肌瘤细胞无影响。突变型MED12 UtSM细胞系的SCD1蛋白水平显著高于野生型MED12 UtSM细胞系。CAY10566处理特异性地降低了突变型MED12 UtSM细胞的细胞活力并增加了细胞凋亡,突变型MED12 UtSM细胞中裂解型caspase 3、裂解型PARP和DDIT3蛋白水平升高,而野生型MED12 UtSM细胞中没有。结论:参与脂质稳态的酶SCD1可能在促进平滑肌瘤生长中发挥重要作用,是平滑肌瘤治疗的新靶点。
{"title":"Stearoyl–coenzyme A desaturase enhances cell survival in human uterine leiomyoma","authors":"Allison S. Komorowski M.D.,&nbsp;John S. Coon V M.S.,&nbsp;Melania Anton B.S.,&nbsp;Azna Zuberi Ph.D.,&nbsp;Olivia Sotos B.S.,&nbsp;Serdar E. Bulun M.D.,&nbsp;Ping Yin M.D., Ph.D.","doi":"10.1016/j.xfss.2025.01.005","DOIUrl":"10.1016/j.xfss.2025.01.005","url":null,"abstract":"<div><h3>Objective</h3><div>Stearoyl-CoA desaturase (SCD1) is an enzyme that catalyzes the conversion of saturated delta-9 fatty acids to monounsaturated fatty acids. SCD1 is highly expressed in various cancers and facilitates cancer cell survival, tumor growth, and metastasis. This study aimed to assess SCD1 expression and function in uterine leiomyoma and matched myometrial tissue and evaluate the impact of SCD1 inhibition on leiomyoma cell viability and apoptosis.</div></div><div><h3>Design</h3><div>Gene set enrichment analysis was performed to determine whether lipid metabolism pathways are dysregulated in leiomyoma. To assess the function of SCD1, primary leiomyoma and myometrial cells, as well as a CRISPR-engineered leiomyoma-relevant <em>MED12</em> mutant human uterine smooth muscle (UtSM) cell line, were treated with <em>SCD1</em> small interfering RNA or a small molecule inhibitor of SCD1, CAY10566. Cell viability and apoptosis assays, real-time quantitative polymerase chain reaction, and immunoblot analyses were performed to evaluate cell function in response to treatment.</div></div><div><h3>Subjects</h3><div>Leiomyoma and myometrial tissues were obtained from premenopausal individuals designated female at birth (n = 30) undergoing myomectomy or hysterectomy.</div></div><div><h3>Exposure</h3><div>SCD1 inhibition by small interfering RNA and CAY10566 treatment.</div></div><div><h3>Main Outcome Measures</h3><div>Messenger RNA (mRNA) and protein levels and cell viability and apoptosis.</div></div><div><h3>Results</h3><div>Gene set enrichment analysis revealed that the cholesterol homeostasis pathway was significantly different in leiomyoma vs. adjacent myometrial tissues. Among the genes in this pathway, SCD1 mRNA levels were found to be significantly higher in leiomyoma than in matched myometrium. SCD1 inhibition by small interfering RNA or CAY10566 decreased antiapoptotic BCL2 mRNA and protein levels and cell viability in primary leiomyoma but not myometrial cells. SCD1 protein levels were significantly higher in the mutant MED12 UtSM cell line than in the wild-type MED12 UtSM cell line. CAY10566 treatment specifically decreased cell viability and increased apoptosis in mutant MED12 UtSM cells, with increased protein levels of cleaved caspase 3, cleaved PARP, and DDIT3 in mutant MED12 UtSM but not in wild-type MED12 UtSM cells.</div></div><div><h3>Conclusion</h3><div>SCD1, an enzyme involved in lipid homeostasis, may play an important role in promoting leiomyoma growth and represents a novel target for the treatment of leiomyoma.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 2","pages":"Pages 202-212"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143525345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Editor-in-Chief 来自总编辑。
Pub Date : 2025-02-01 DOI: 10.1016/j.xfss.2025.01.001
William H. Catherino MD, PhD
{"title":"From the Editor-in-Chief","authors":"William H. Catherino MD, PhD","doi":"10.1016/j.xfss.2025.01.001","DOIUrl":"10.1016/j.xfss.2025.01.001","url":null,"abstract":"","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"6 1","pages":"Pages 1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
F&S science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1